These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 15052667)

  • 1. DC-SIGN: binding receptor for HCV?
    Feng ZH; Wang QC; Nie QH; Jia ZS; Zhou YX
    World J Gastroenterol; 2004 Apr; 10(7):925-9. PubMed ID: 15052667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DC-SIGN: binding receptors for hepatitis C virus.
    Wang QC; Feng ZH; Nie QH; Zhou YX
    Chin Med J (Engl); 2004 Sep; 117(9):1395-400. PubMed ID: 15377434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR.
    Pöhlmann S; Zhang J; Baribaud F; Chen Z; Leslie GJ; Lin G; Granelli-Piperno A; Doms RW; Rice CM; McKeating JA
    J Virol; 2003 Apr; 77(7):4070-80. PubMed ID: 12634366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DC-SIGN: a novel HIV receptor on DCs that mediates HIV-1 transmission.
    Geijtenbeek TB; van Kooyk Y
    Curr Top Microbiol Immunol; 2003; 276():31-54. PubMed ID: 12797442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus.
    Cormier EG; Durso RJ; Tsamis F; Boussemart L; Manix C; Olson WC; Gardner JP; Dragic T
    Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14067-72. PubMed ID: 15371595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation.
    Ludwig IS; Lekkerkerker AN; Depla E; Bosman F; Musters RJ; Depraetere S; van Kooyk Y; Geijtenbeek TB
    J Virol; 2004 Aug; 78(15):8322-32. PubMed ID: 15254204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DC-SIGN (dendritic cell-specific ICAM-grabbing non-integrin) and DC-SIGN-related (DC-SIGNR): friend or foe?
    Soilleux EJ
    Clin Sci (Lond); 2003 Apr; 104(4):437-46. PubMed ID: 12653690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional evaluation of DC-SIGN monoclonal antibodies reveals DC-SIGN interactions with ICAM-3 do not promote human immunodeficiency virus type 1 transmission.
    Wu L; Martin TD; Vazeux R; Unutmaz D; KewalRamani VN
    J Virol; 2002 Jun; 76(12):5905-14. PubMed ID: 12021323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DC-SIGN and L-SIGN Are Attachment Factors That Promote Infection of Target Cells by Human Metapneumovirus in the Presence or Absence of Cellular Glycosaminoglycans.
    Gillespie L; Gerstenberg K; Ana-Sosa-Batiz F; Parsons MS; Farrukee R; Krabbe M; Spann K; Brooks AG; Londrigan SL; Reading PC
    J Virol; 2016 Sep; 90(17):7848-63. PubMed ID: 27334579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells.
    Burleigh L; Lozach PY; Schiffer C; Staropoli I; Pezo V; Porrot F; Canque B; Virelizier JL; Arenzana-Seisdedos F; Amara A
    J Virol; 2006 Mar; 80(6):2949-57. PubMed ID: 16501104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HCV and HIV binding lectin, DC-SIGNR, is expressed at all stages of HCV induced liver disease.
    Cole G; Coleman N; Soilleux E
    J Clin Pathol; 2004 Jan; 57(1):79-80. PubMed ID: 14693842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells mediate herpes simplex virus infection and transmission through the C-type lectin DC-SIGN.
    de Jong MAWP; de Witte L; Bolmstedt A; van Kooyk Y; Geijtenbeek TBH
    J Gen Virol; 2008 Oct; 89(Pt 10):2398-2409. PubMed ID: 18796707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of DC-SIGN in Lassa virus entry into human dendritic cells.
    Goncalves AR; Moraz ML; Pasquato A; Helenius A; Lozach PY; Kunz S
    J Virol; 2013 Nov; 87(21):11504-15. PubMed ID: 23966408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of DC-SIGN/R interaction with human immunodeficiency virus type 1 gp120 and ICAM molecules favors the receptor's role as an antigen-capturing rather than an adhesion receptor.
    Snyder GA; Ford J; Torabi-Parizi P; Arthos JA; Schuck P; Colonna M; Sun PD
    J Virol; 2005 Apr; 79(8):4589-98. PubMed ID: 15795245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles.
    Lozach PY; Amara A; Bartosch B; Virelizier JL; Arenzana-Seisdedos F; Cosset FL; Altmeyer R
    J Biol Chem; 2004 Jul; 279(31):32035-45. PubMed ID: 15166245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus.
    Pöhlmann S; Baribaud F; Lee B; Leslie GJ; Sanchez MD; Hiebenthal-Millow K; Münch J; Kirchhoff F; Doms RW
    J Virol; 2001 May; 75(10):4664-72. PubMed ID: 11312337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans.
    Alvarez CP; Lasala F; Carrillo J; Muñiz O; Corbí AL; Delgado R
    J Virol; 2002 Jul; 76(13):6841-4. PubMed ID: 12050398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microdomains of the C-type lectin DC-SIGN are portals for virus entry into dendritic cells.
    Cambi A; de Lange F; van Maarseveen NM; Nijhuis M; Joosten B; van Dijk EM; de Bakker BI; Fransen JA; Bovee-Geurts PH; van Leeuwen FN; Van Hulst NF; Figdor CG
    J Cell Biol; 2004 Jan; 164(1):145-55. PubMed ID: 14709546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fatal attraction: Mycobacterium tuberculosis and HIV-1 target DC-SIGN to escape immune surveillance.
    van Kooyk Y; Appelmelk B; Geijtenbeek TB
    Trends Mol Med; 2003 Apr; 9(4):153-9. PubMed ID: 12727141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DCIR interacts with ligands from both endogenous and pathogenic origin.
    Bloem K; Vuist IM; van den Berk M; Klaver EJ; van Die I; Knippels LM; Garssen J; García-Vallejo JJ; van Vliet SJ; van Kooyk Y
    Immunol Lett; 2014; 158(1-2):33-41. PubMed ID: 24239607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.